Goldman Sachs’s Apyx Medical APYX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,127
| Closed | -$52.2K | – | 4929 |
|
|
2023
Q1 | $52.2K | Buy |
+18,127
| New | +$52.2K | ﹤0.01% | 4759 |
|
|
2022
Q3 | – | Sell |
-22,241
| Closed | -$130K | – | 5467 |
|
|
2022
Q2 | $130K | Buy |
22,241
+5,580
| +33% | +$32.6K | ﹤0.01% | 5035 |
|
|
2022
Q1 | $109K | Sell |
16,661
-94,058
| -85% | -$615K | ﹤0.01% | 5286 |
|
|
2021
Q4 | $1.42M | Sell |
110,719
-52,489
| -32% | -$673K | ﹤0.01% | 3751 |
|
|
2021
Q3 | $2.26M | Sell |
163,208
-23,631
| -13% | -$327K | ﹤0.01% | 3387 |
|
|
2021
Q2 | $1.93M | Buy |
186,839
+26,002
| +16% | +$268K | ﹤0.01% | 3529 |
|
|
2021
Q1 | $1.55M | Buy |
160,837
+4,484
| +3% | +$43.3K | ﹤0.01% | 3595 |
|
|
2020
Q4 | $1.13M | Sell |
156,353
-15,804
| -9% | -$114K | ﹤0.01% | 3391 |
|
|
2020
Q3 | $811K | Buy |
172,157
+25,370
| +17% | +$120K | ﹤0.01% | 3423 |
|
|
2020
Q2 | $815K | Buy |
146,787
+107,448
| +273% | +$597K | ﹤0.01% | 3346 |
|
|
2020
Q1 | $141K | Sell |
39,339
-173,100
| -81% | -$620K | ﹤0.01% | 4073 |
|
|
2019
Q4 | $1.8M | Buy |
212,439
+195,417
| +1,148% | +$1.65M | ﹤0.01% | 2997 |
|
|
2019
Q3 | $115K | Buy |
17,022
+4,480
| +36% | +$30.3K | ﹤0.01% | 4031 |
|
|
2019
Q2 | $84K | Sell |
12,542
-136,577
| -92% | -$915K | ﹤0.01% | 4024 |
|
|
2019
Q1 | $941K | Buy |
+149,119
| New | +$941K | ﹤0.01% | 3287 |
|